Mirus Bio
Dale Gordon has an extensive background in the biopharmaceutical and research industries. Dale currently serves as the CEO of Mirus Bio LLC, a company specializing in transfection products for gene therapy, recombinant protein, and stem cell applications. Prior to this, they held the position of CEO and Member of the Board of Directors at Gemini Bio, a leading supplier of cell culture media and reagents. Dale also has experience as the Chief Commercial Officer at Human Longevity, Inc. and as the GM of Commercial at GE Healthcare. In addition, Dale Gordon worked at Merck Millipore in various roles, including Head of Commercial Marketing, Head of North American Sales, and Head of Global Sales Operations. Dale possesses a strong background in sales and commercial operations in the life sciences industry.
Dale Gordon has a background in Microbiology and Cell Science from the University of Florida. They have not specified the start or end dates of their education at the university. Additionally, Dale has obtained a certification as a Talent Optimization Consultant from The Predictive Index in September 2021.
Mirus Bio
1 followers
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina,Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.